La Creis R. Kidd

Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.

C. Nelson, La Creis R. Kidd, Jurgita Sauvageot et al. · PubMed · 2001 · 149 citations

Cpg Island Hypermethylation, Chemoprevention Strategy, Prostate Cells +17

Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: relationship to cytochrome P4501A2 and N-acetyltransferase activity.

W.G. Stillwell, La Creis R. Kidd, J S Wishnok et al. · PubMed · 1997 · 80 citations

Phase Ii Conjugates, Urinary Excretion, Chemical Biology +18

Urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in White, African-American, and Asian-American men in Los Angeles County.

La Creis R. Kidd, W.G. Stillwell, M C Yu et al. · PubMed · 1999 · 66 citations

Dietary Exposure, Urinary Excretion, Pathology +17

Association of IL-10 polymorphisms with prostate cancer risk and grade of disease

Jessica M. Faupel‐Badger, La Creis R. Kidd, Demetrius Albanes et al. · Cancer Causes & Control · 2007 · 61 citations

Urology, Epidemiology, Cancer Epidemiology +11

Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among Men of African Descent: A case-control study

Nicole Lavender, Marnita L. Benford, Tiva T. VanCleave et al. · BMC Cancer · 2009 · 53 citations · Full text